Ann Marie Gillenwater

Ann Marie Gillenwater is a Professor at The University of Texas MD Anderson Cancer Center, specializing in head and neck oncology and oral cancer research. Her work integrates radiation oncology, cancer imaging, and biomedical imaging to advance early detection and treatment of epithelial malignancies. Her recent research focuses on deep-learning-enabled endomicroscopy and array-microscopy systems for real-time in vivo imaging and intraoperative tumor margin assessment. She has led clinical trials on ASP-1929 photoimmunotherapy combined with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma, and published long-term outcomes on chemotherapy for laryngeal cancer. Her international collaborations and translational imaging innovations position her at the forefront of precision oncology.